BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1279725)

  • 1. Two-color flow cytometric analysis of CD34-positive peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor for autotransplantation.
    Inaba T; Shimazaki C; Ashihara E; Ohkawa K; Oku N; Gotoh H; Fujita N; Tsuji H; Nakagawa M
    Prog Clin Biol Res; 1992; 377():561-7. PubMed ID: 1279725
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring of kinetics of CD34 positive cells by immunomagnetic beads during peripheral blood stem cell harvest for autotransplantation.
    Oku N; Shimazaki C; Ashihara E; Ohkawa K; Gotoh H; Inaba T; Murakami S; Itoh K; Fujita N; Tsuji H
    Prog Clin Biol Res; 1992; 377():553-60. PubMed ID: 1279724
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow.
    Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M
    Prog Clin Biol Res; 1994; 389():331-7. PubMed ID: 7535439
    [No Abstract]   [Full Text] [Related]  

  • 4. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.
    Shimazaki C; Oku N; Ashihara E; Okawa K; Goto H; Inaba T; Ito K; Fujita N; Tsuji H; Murakami S
    Bone Marrow Transplant; 1992 Oct; 10(4):341-6. PubMed ID: 1384902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 analysis in peripheral blood correlates with colony forming capacity--an update.
    Fritsch G; Emminger W; Buchinger P; Printz D; Gadner H
    Prog Clin Biol Res; 1992; 377():531-6. PubMed ID: 1279721
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
    Teofili L; Iovino MS; Sica S; Pierelli L; Menichella G; De Stefano V; Rumi C; Leone G
    Exp Hematol; 1994 Sep; 22(10):990-5. PubMed ID: 7522187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor.
    Suzue T; Kawano Y; Takaue Y; Kuroda Y
    Exp Hematol; 1994 Aug; 22(9):888-92. PubMed ID: 7520392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Alemán-Hoey DD; Arizpe Bravo D; Martin-López A; Ocejo Rodríguez A
    Rev Invest Clin; 1993; 45(5):479-80. PubMed ID: 7510900
    [No Abstract]   [Full Text] [Related]  

  • 12. CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
    O'Kane-Murphy B; Jackson JD; Kuszynski C; Costas P; Wang PN; Warkentin PI; Kessinger A
    Prog Clin Biol Res; 1994; 389():371-6. PubMed ID: 7535444
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of peripheral blood stem cells mobilized with granulocyte colony-stimulating factor with or without prior standard-dose chemotherapy in patients with malignancy.
    Kobayashi N; Kasai M; Masauzi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Hashino S; Tanaka J; Imamura M
    Jpn J Clin Oncol; 1995 Dec; 25(6):250-7. PubMed ID: 8523821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors.
    Handgretinger R; Klingebiel T; Herter M; Lang P; Gisselhart A; Dopfer R; Scheel-Walter H; Ehrlich H; Niethammer D
    Prog Clin Biol Res; 1994; 389():479-86. PubMed ID: 7535457
    [No Abstract]   [Full Text] [Related]  

  • 15. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors.
    Corringham RE; Ho AD
    Blood; 1995 Sep; 86(5):2052-4. PubMed ID: 7544651
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
    Jackson JD; Letheby B; O'Kane Murphy B; Costas P; Wang PN; Bishop MR; Kessinger A; Warkentin PI
    Prog Clin Biol Res; 1994; 389():471-7. PubMed ID: 7535456
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
    Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
    Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy.
    Bender JG; Unverzagt KL; Walker DE; Lee W; Lum L; Van Epps DE; Williams SF; To LB
    Prog Clin Biol Res; 1992; 377():575-82. PubMed ID: 1279727
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the collection efficiency and characteristics of peripheral blood progenitor cells mobilized by G-CSF administration in the steady state versus postmyelosuppressive chemotherapy.
    Masauzi N; Kobayashi N; Suzuki G; Ohizumi H; Ogasawara M; Kiyama Y; Naohara T; Saitoh M; Higa T; Kasai M
    Transplant Proc; 1996 Jun; 28(3):1741-5. PubMed ID: 8658864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.